|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash and cash equivalents | ||||||||||
| Prepaid expenses | ||||||||||
| Accounts receivable, net of allowance for credit losses of $721 and $144 at June 30, 2023 and December 31, 2022 | ||||||||||
| Inventories | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total current assets | ||||||||||
| Investments held in Trust Account | ||||||||||
| Noncurrent assets: | ||||||||||
| Property and equipment, net | ||||||||||
| Goodwill | ||||||||||
| Intangible assets, net | ||||||||||
| Non-marketable equity securities | ||||||||||
| Capitalized equity issuance costs and other assets | ||||||||||
| Deferred tax assets | ||||||||||
| Right-of-use assets | ||||||||||
| Total assets | ||||||||||
| LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | ||||||||||
| Accrued expenses and other current liabilities | ||||||||||
| Due to related party | ||||||||||
| Note payable | ||||||||||
| Current portion of long-term debt | ||||||||||
| Current portion of deferred revenue | ||||||||||
| Payable to Kinduct sellers – current | ||||||||||
| Total current liabilities | ||||||||||
| Derivative warrant liabilities | ||||||||||
| Deferred underwriting commissions | ||||||||||
| Noncurrent liabilities: | ||||||||||
| Long-term portion of term debt | ||||||||||
| Convertible notes, net – related party (Note 12) | ||||||||||
| Warrant liabilities | ||||||||||
| Deferred revenue, net of current portion | ||||||||||
| Deferred tax liabilities, net | ||||||||||
| Operating lease liabilities and other non-current liabilities | ||||||||||
| Total liabilities | ||||||||||
| Mezzanine equity | ||||||||||
| Redeemable Convertible Preferred Stock | ||||||||||
| Nonredeemable Convertible Preferred Stock | ||||||||||
| Total mezzanine equity | ||||||||||
| Stockholders’ equity (deficit) | ||||||||||
| Common stock, $0.00001 par value. 900,000,000 shares authorized, 50,907,431 shares issued and outstanding at June 30, 2023; 46,430,391 shares authorized, 6,231,947 shares issued and outstanding at December 31, 2022 | ||||||||||
| Class B ordinary shares, $0.0001 par value; 30,000,000 shares authorized; 8,125,000 shares issued and outstanding as of December 31, 2022 and 2021 | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated other comprehensive loss | ||||||||||
| Accumulated deficit | ||||||||||
| Total Movella stockholders’ equity (deficit) | ||||||||||
| Non-controlling interest in subsidiaries | ||||||||||
| Total stockholders’ equity (deficit) | ||||||||||
| Total liabilities, mezzanine equity and stockholders’ equity |
Loading...